The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia

被引:0
作者
Abul-fotouh Ahmed
Aref Maarouf
Essam Shalaby
Ahmad H. Gabr
Ashraf Shahin
Ammar Ghobish
机构
[1] Al-Azhar University,Department of Urology, Faculty of Medicine
[2] Salman Bin Abdulaziz University,Department of Urology, Faculty of Medicine
[3] Zagazig University,Department of Urology, Faculty of Medicine
[4] King Abdullah Hospital,Department of Urology
[5] Suez Canal University,Department of Urology, Faculty of Medicine
[6] King Khalid Hospital,Department of Urology
[7] Minia University,Department of Urology, Faculty of Medicine
来源
World Journal of Urology | 2015年 / 33卷
关键词
Desmopressin; Nocturia; Prostate hyperplasia; Tamsulosin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:649 / 657
页数:8
相关论文
共 118 条
[1]  
van Kerrebroeck P(2002)The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 179-183
[2]  
Abrams P(2009)Nocturia and disturbed sleep in the elderly Sleep Med 10 540-548
[3]  
Chaikin D(2010)Nocturia frequency, bother, and quality of life: How often is too often? A population-based study in Finland Eur Urol 57 488-496
[4]  
Donovan J(2003)Nocturia and benign prostatic hyperplasia Urology 61 786-790
[5]  
Fonda D(2007)Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study Eur Urol 52 221-229
[6]  
Jackson S(2013)Diagnosis of BPH and treatment of LUTS among GPs: a European survey Int J Clin Pract 67 114-119
[7]  
Jennum P(2011)Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study J Urol 185 219-223
[8]  
Johnson T(2003)Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia BJU Int 91 190-195
[9]  
Lose G(2010)The role of nocturia in the quality of life of men with lower urinary tract symptoms BJU Int 105 1141-1146
[10]  
Mattiasson A(2014)Efficacy and tolerability of tamsulosin 0.4 mg in Asian patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia refractory to tamsulosin 0.2 mg: a randomized placebo controlled trial Int J Urol 21 677-682